Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Health Catalyst, Inc - Common stock (NQ:HCAT)

3.875 -0.265 (-6.40%)
Streaming Delayed Price Updated: 11:54 AM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Health Catalyst, Inc - Common stock

< Previous 1 2 3 4 5 6 Next >
3 Small-Cap Stocks in Hot Water
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
Q4 Earnings Outperformers: Samsara (NYSE:IOT) And The Rest Of The Data Analytics Stocks
Let’s dig into the relative performance of Samsara (NYSE:IOT) and its peers as we unravel the now-completed Q4 data analytics earnings season. 
Via StockStory
1 Software Stock with Exciting Potential and 2 to Ignore
From commerce to culture, software is digitizing every aspect of our lives. This secular theme has materialized in superior earnings growth and stock price performance for most SaaS companies, and over... 
Via StockStory
Topics Stocks
Exposures US Equities
10 Analysts Have This To Say About Health Catalyst
Via Benzinga
Earnings Scheduled For February 26, 2025
Via Benzinga
Beyond The Numbers: 8 Analysts Discuss Health Catalyst Stock
Via Benzinga
Breaking Down Health Catalyst: 8 Analysts Share Their Views
Via Benzinga
The Latest Analyst Ratings For Health Catalyst
Via Benzinga
Why Health Catalyst (HCAT) Shares Are Trading Lower Today
Shares of healthcare software provider Health Catalyst (NASDAQ:HCAT) fell 20.9% in the morning session after the company reported poor fourth-quarter results, with full-year revenue guidance missing... 
Via StockStory
Health Catalyst’s (NASDAQ:HCAT) Q4 Earnings Results: Revenue In Line With Expectations, Growth To Accelerate Next Year
Healthcare software provider Health Catalyst (NASDAQ:HCAT) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6% year on year to $79.61 million. On the other hand, next quarter’s... 
Via StockStory
Health Catalyst Reports Fourth Quarter and Year End 2024 Results
From Health Catalyst, Inc.
Via GlobeNewswire
Health Catalyst (HCAT) Q4 Earnings: What To Expect
Healthcare software provider Health Catalyst (NASDAQ:HCAT) will be reporting results tomorrow after market hours. Here’s what you need to know. 
Via StockStory
Health Catalyst to Participate in Upcoming Investor Conference
From Health Catalyst, Inc.
Via GlobeNewswire
Health Catalyst to Announce Fourth Quarter and Full Year 2024 Operating Results and Host Conference Call on Wednesday, February 26, 2025
From Health Catalyst, Inc.
Via GlobeNewswire
Data Analytics Stocks Q3 Highlights: Domo (NASDAQ:DOMO)
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the data analytics stocks, including Domo (NASDAQ:DOMO) and its peers. 
Via StockStory
Health Catalyst to Participate in Upcoming Investor Conference
From Health Catalyst, Inc.
Via GlobeNewswire
A Look Back at Data Analytics Stocks’ Q3 Earnings: Palantir (NASDAQ:PLTR) Vs The Rest Of The Pack
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Palantir (NASDAQ:PLTR) and the... 
Via StockStory
Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound
Check out these three health-tech stocks with prospects of recovery in 2025 after seeing shares decline significantly in 2024. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Winners And Losers Of Q3: Health Catalyst (NASDAQ:HCAT) Vs The Rest Of The Data Analytics Stocks
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Health Catalyst (NASDAQ:HCAT) and its peers. 
Via StockStory
Q3 Data Analytics Earnings Review: First Prize Goes to Samsara (NYSE:IOT)
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the data analytics industry, including Samsara (NYSE:IOT) and its peers. 
Via StockStory
Futures Slump As Yields, Dollar Soar
In premarket trading Quantum stocks tumbled after Nvidia CEO Jensen Huang said that “very useful” quantum computers are likely decades away. 
Via Talk Markets
Topics Commodities Stocks / Equities
Q3 Earnings Highs And Lows: Amplitude (NASDAQ:AMPL) Vs The Rest Of The Data Analytics Stocks
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Amplitude (NASDAQ:AMPL) and its peers. 
Via StockStory
Health Catalyst (HCAT): Buy, Sell, or Hold Post Q3 Earnings?
Over the past six months, Health Catalyst has been a great trade, beating the S&P 500 by 7.9%. Its stock price has climbed to $7.09, representing a healthy 17.2% increase. This was partly thanks to its... 
Via StockStory
Topics Stocks
Exposures US Equities
Health Catalyst to Participate in Upcoming Investor Conference
From Health Catalyst, Inc.
Via GlobeNewswire
Earnings To Watch: Domo (DOMO) Reports Q3 Results Tomorrow
Data visualization and business intelligence company Domo (NASDAQ:DOMO) will be reporting earnings tomorrow after the bell. Here’s what you need to know. 
Via StockStory
What To Expect From Samsara’s (IOT) Q3 Earnings
Internet of Things company Samsara (NYSE:IOT) will be announcing earnings results tomorrow after market hours. Here’s what to look for. 
Via StockStory
Starbucks To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Health Catalyst to Participate in Upcoming Investor Conferences
From Health Catalyst, Inc.
Via GlobeNewswire
Health Catalyst to Participate in Upcoming Investor Conference
From Health Catalyst, Inc.
Via GlobeNewswire
Health Catalyst (NASDAQ:HCAT) Posts Q3 Sales In Line With Estimates
Healthcare software provider Health Catalyst (NASDAQ:HCAT) met Wall Street’s revenue expectations in Q3 CY2024, with sales up 3.5% year on year to $76.35 million. The company expects next quarter’s... 
Via StockStory
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.